FAICIC Clinical Research
FAICIC es un centro de investigación clínica con la misión de proveer servicios de investigación clínica para la innovación de tratamientos médicos, cuidando siempre la atención y calidad humana y cumpliendo con los mas altos estándares que la industria demanda en las áreas oncológica, cardiometabólica y autoinmune entre otras.Av. 16 de Septiembre 1165, Ricardo Flores Magón, 91900 Veracruz, Veracruz
Websitehttp://www.faicic.com.mx
Select an option
I am a doctor
I am a sponsor
Specializations
Pediatría
Nefrología
Oncología
Our team
Medical staff
Eduardo Tlaxalo
Astrid Hernández Góngora
Aldo Miguel Lopez Dominguez
Leslie Mariel Paez Cortes
David Santeliz Fuentes
Gustavo Martínez
Erika Castillo Gutiérrez
Sandro Fabricio Ávila Pardo
Francisco Salazar Martínez
Alejandro Quintin Barrat
Jesus Antonio Romacho Beltran
Silvano Omar Martínez Pérez
Ricardo Remes
Jose Omar Porras Damian
Denisse Glez
Marielena Acosta Delgadillo
Abigail Reyes
David Reyes Barrios
Open studies
Breast Cancer
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer - ASCENT-03 - Gilead SciencesSee more
Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer - OVELIA - Tolmar Inc.See more
Cardiovascular disease
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation - ZEUS - Novo Nordisk A/SSee more
Crohn's disease
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease - CULTIVATE - Arena PharmaceuticalsSee more
Renal disease
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation - ZEUS - Novo Nordisk A/SSee more
Skin cancer
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma - Regeneron PharmaceuticalsSee more
